Today: 4 March 2026
Browse Category

Stock Market 20 October 2025 - 21 October 2025

IDFC First Bank Stock Soars 7% After Profit Surge – What’s Next for its Share Price?

IDFC First Bank Stock Soars 7% After Profit Surge – What’s Next for its Share Price?

IDFC First Bank shares jumped nearly 7% to ₹77 on October 20, 2025, after Q2 FY26 net profit rose 75.5% year-on-year to ₹352.3 crore. Net interest income increased 6.8% to ₹5,113 crore, while gross NPAs held at 1.86%. Brokerages raised price targets, with Jefferies moving to ₹85. CEO V. Vaidyanathan said asset quality remains steady and expects further improvement in funding costs.
21 October 2025
HeartCore (HTCR) Stock Soars on Dividend Surprise – Analysts Weigh In

HeartCore (HTCR) Stock Soars on Dividend Surprise – Analysts Weigh In

HeartCore Enterprises (Nasdaq: HTCR) jumped about 40% in after-hours trading on Oct. 20 after announcing a one-time $0.13 per share dividend, yielding roughly 17.8%. The stock traded near $0.71 on Oct. 21, within a 52-week range of $0.39–$3.38. Q2 2025 results showed $4.7 million revenue and $1.1 million net income, reversing a prior loss. Record date for the dividend is Nov. 10, with payment set for Nov. 17.
21 October 2025
ICICI Bank Stock at ₹1,380 Today – Analysts Eye ₹1,800 Target After Q2 Earnings Shock

ICICI Bank Stock at ₹1,380 Today – Analysts Eye ₹1,800 Target After Q2 Earnings Shock

ICICI Bank shares traded near ₹1,380 on October 21, down 0.5% after a 3% drop post-earnings. Q2 net profit rose 5% year-on-year to ₹12,359 crore, but moderated loan growth and a slight uptick in gross NPA weighed on sentiment. The stock remains up about 8.5% year-to-date, outperforming broader indices. Analyst targets range from ₹1,680 to ₹1,800, citing strong margins and asset quality.
21 October 2025
South Indian Bank Stock Soars to Record High on Q2 Earnings – Will ₹50 Be Next?

South Indian Bank Stock Soars to Record High on Q2 Earnings – Will ₹50 Be Next?

South Indian Bank shares hit a record ₹38.44 on October 21, 2025, after strong Q2 earnings and a surge in trading volumes. Net profit rose 8.2% to ₹351.6 crore, while gross NPA fell to 2.93%. High-net-worth investor Aditya Kumar Halwasiya bought a 0.76% stake during the rally. Brokerages raised targets to ₹42, citing improved fundamentals and steady loan growth.
RRP Semiconductor Stock Skyrockets 57,000%; Sachin Tendulkar Link Debunked

Mystery Chip Stock Soars ~57,000% to ₹9,500 – RRP Semiconductor’s Frenzy Triggers Bubble Fears

RRP Semiconductor Ltd shares soared from ₹15 in April 2024 to ₹9,478 on October 21, 2025, locking at the 2% upper circuit. The Bombay Stock Exchange imposed strict trading curbs, citing a price rise “not commensurate with the financials.” RRP denied rumors linking it to Sachin Tendulkar or government land. The company reported only a few crores in profit and has just two employees.
21 October 2025
Duralex Crisis Deepens: Iconic French Glassmaker Seeks €5M Lifeline from Public Investors

Duralex Crisis Deepens: Iconic French Glassmaker Seeks €5M Lifeline from Public Investors

Duralex, saved by its workers in 2024, remains financially unstable, with 2025 sales projected below the €35 million break-even point. The glassmaker launched a €5 million public crowdfunding campaign, offering 8% returns, to fund new products and factory upgrades. Director General François Marciano says banks remain cautious until results improve. Employees have cut costs and rotated store shifts to avoid new hires.
21 October 2025
Beam Therapeutics Stock Soars on FDA Backing – Analysts Forecast ~70% Upside

Beam Therapeutics Stock Soars on FDA Backing – Analysts Forecast ~70% Upside

Beam Therapeutics shares rose about 17% to $30 after the FDA granted RMAT and Orphan Drug designations to its lead gene-editing programs, BEAM-101 and BEAM-302. Early trial data showed BEAM-302 raised protective AAT levels and BEAM-101 produced durable increases in fetal hemoglobin. Wall Street’s average 12-month price target is $45–46, implying roughly 70–80% upside.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 21.10.2025

Weatherford International reported Q3 earnings of $81 million, or $1.12 per share, missing analyst estimates and down from $157 million a year earlier. Revenue dropped 12.6% to $1.232 billion. U.S. stocks ended mixed as the Dow rose 0.5%, the S&P 500 was flat, and the Nasdaq slipped. General Motors raised its forecast, while Netflix fell after missing targets.
21 October 2025
SPRO Stock Skyrockets on Breakthrough Oral Antibiotic Data

SPRO Stock Skyrockets on Breakthrough Oral Antibiotic Data

Spero shares closed at $2.29 on Oct. 20, 2025, up 3.6%, after reporting Phase 3 trial results showing oral tebipenem HBr matched IV imipenem in overall success (58.5% vs 60.2%) at IDWeek. The stock has surged over 120% year-to-date, trading between $0.51 and $3.22. GSK plans an FDA submission in Q4. Analyst 12-month targets average $5, but ratings remain mixed following a recent Zacks downgrade.
Replimune Stock Rockets 100% on FDA Nod – Analysts Eye Upside

Replimune Stock Rockets 100% on FDA Nod – Analysts Eye Upside

Replimune shares jumped 99% to $8.94 on Oct. 20, 2025, after the FDA accepted its resubmitted BLA for lead cancer therapy RP1 plus nivolumab, setting a PDUFA decision date for April 10, 2026. New trial data showed a 44% response rate in acral melanoma. The stock’s rebound follows a 73% plunge in July after an FDA rejection. Market cap stands near $698 million.
21 October 2025
Beyond Meat (BYND) Stock Skyrockets 50% Amid Meme Mania – Turnaround or Dead Cat Bounce?

Beyond Meat (BYND) Stock Skyrockets 50% Amid Meme Mania – Turnaround or Dead Cat Bounce?

Beyond Meat shares surged 128% to $1.47 on Oct. 20 after a volatile week driven by a short squeeze and heavy trading volumes. The company completed a debt-for-equity swap on Oct. 15, cutting $900 million in debt but diluting shareholders as outstanding shares jumped from 76.7 million to 392 million. Sales and profits continue to fall, and analysts remain broadly bearish.
21 October 2025
Netflix Stock Soars: Wall Street Targets $1,500 as Earnings Loom

Netflix Stock Soars: Wall Street Targets $1,500 as Earnings Loom

Netflix shares closed at $1,238.56 on Oct. 20, up 3.3% and near all-time highs ahead of Q3 earnings. Analysts expect Q3 revenue of about $11.5 billion and EPS of $6.9–7.0, with focus shifting to advertising and margins. Netflix ended Q2 with 302 million paid subscribers and $2.3 billion in free cash flow. Wall Street remains bullish, with most analysts rating the stock a “Buy.”
Cleveland-Cliffs Stock Rockets on Tariffs and Rare-Earth Push – But Caution Remains

Cleveland-Cliffs Stock Rockets on Tariffs and Rare-Earth Push – But Caution Remains

Cleveland-Cliffs shares surged nearly 20% on Oct. 20, closing at $15.50 after Q3 results and rare-earth exploration plans. The company posted Q3 revenue of $4.73 billion and an adjusted loss of $0.45 per share, narrower than expected. Executives credited new U.S. steel tariffs for stronger demand and multi-year auto contracts. The stock is up about 42% year-to-date, far outpacing peers.
21 October 2025
Cookie Craze & Coffee Buzz: 7 Brew Drive-Thru and Crumbl Cookies Coming to Salisbury

Cookie Craze & Coffee Buzz: 7 Brew Drive-Thru and Crumbl Cookies Coming to Salisbury

Crumbl Cookies leased 2,300 square feet at 2717 N. Salisbury Blvd. for its first Eastern Shore Maryland store, set to open November 2025. 7 Brew will open its first Salisbury drive-thru at 1503 S. Salisbury Blvd., with construction starting soon. Crumbl operates over 1,000 locations nationwide. 7 Brew reached 500 U.S. stores by October 2025 amid rapid drive-thru coffee growth.
21 October 2025
White House U-Turn: Student Loan Forgiveness Approved for Millions After Court Deal

White House U-Turn: Student Loan Forgiveness Approved for Millions After Court Deal

The Trump administration agreed on Oct. 17, 2025, to resume canceling federal student debt for 2–2.5 million borrowers in income-driven repayment plans, under a court settlement with the AFT. The Education Department will process loan discharges for those who made 20–25 years of payments. Forgiven debt through 2025 will not trigger federal tax bills. Notices to eligible borrowers began arriving in early October.
21 October 2025
Apple Stock Hits New Heights: iPhone 17 Supercycle, Analyst Split, and 2025 Outlook Revealed

Apple Stock Soars to Record High on iPhone 17 “Supercycle” Buzz – Will the Rally Last?

Apple stock closed at a record $262.24 on Oct. 20, up nearly 4% after iPhone 17 sales jumped 14% over last year’s launch in the U.S. and China. Loop Capital and Evercore ISI raised ratings and targets, but Jefferies downgraded the stock, citing high expectations. Apple neared a $4 trillion valuation. Earnings are due Oct. 30, with analysts expecting $101 billion in revenue.
20 October 2025
Beam Therapeutics Stock Soars on Gene-Editing Buzz – Analysts Project Big Upside

Beam Therapeutics Stock Soars on Gene-Editing Buzz – Analysts Project Big Upside

Beam Therapeutics shares jumped 17% to $30.35 on Oct. 20, 2025, marking their highest level since early 2024. The rally followed bullish technical signals and positive clinical updates for its gene-editing therapies. Analysts at Jefferies and H.C. Wainwright reiterated Buy ratings, with price targets up to $80. Beam ended Q2 with $1.2 billion in cash, enough to fund operations into 2028.
Celcuity Stock Skyrockets 40% to Record High on ‘Practice-Changing’ Cancer Trial Results

Celcuity Stock Skyrockets 40% to Record High on ‘Practice-Changing’ Cancer Trial Results

Celcuity shares jumped over 40% Monday to a record near $80 after Phase 3 trial data showed its drug gedatolisib cut risk of progression or death by 76% in advanced HR+/HER2- breast cancer. The company confirmed full enrollment of the PIK3CA-mutant cohort, with final results expected by mid-2026. Needham raised its price target to $95. Celcuity’s market cap topped $2.2 billion.
Go toTop